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ABSTRACT 
 
Cellular prion protein (PrPC) is expressed in a wide variety of stem cells in which regulates their self-
renewal as well as differentiation potential. In this study we investigated the presence of PrPC in hu-
man dental pulp-derived stem cells (hDPSCs) and its role in neuronal differentiation process. We 
show that hDPSCs expresses early PrPC at low concentration and its expression increases after two 
weeks of treatment with EGF/bFGF. Then, we analyzed the association of PrPC with gangliosides and 
EGF receptor (EGF-R) during neuronal differentiation process. PrPC associates constitutively with 
GM2 in control hDPSCs and with GD3 only after neuronal differentiation. Otherwise, EGF-R associ-
ates weakly in control hDPSCs and more markedly after neuronal differentiation.  
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To analyze the functional role of PrPC in the signal pathway mediated by EGF/EGF-R, a siRNA PrP 
was applied to ablate PrPC and its function. The treatment with siRNA PrP significantly prevented Akt 
and ERK1/2 phosphorylation induced by EGF.  
Moreover, siRNA PrP treatment significantly prevented neuronal-specific antigens expression induced 
by EGF/bFGF, indicating that cellular prion protein is essential for EGF/bFGF-induced hDPSCs differ-
entiation.  
These results suggest that PrPC interact with EGF-R within lipid rafts, playing a role in the multimo-
lecular signaling complexes involved in hDPSCs neuronal differentiation.  
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1. INTRODUCTION 
  
Stem cells are primitive and unspecialized cells with the ability to develop into different cells types us-
ing a process called cell differentiation [1]. The concept of “staminality” is often associated with em-
bryonic stem cells but in recent years there has been a growing interest in adult stem cells that do not 
require embryo manipulation. 
A kind of adult stem cells, mesenchymal stem cells, show self-renewal, multilineage differentiation and 
in vitro proliferation ability after long-term cultures [2]. This kind of cells have been isolated from sev-
eral tissues, including bone marrow, umbilical cord blood, human dental pulp and adipose tissue [3-6]. 
Their proliferative capacity, multipotency, and high differentiation power besides the ability to repair 
tissues make these cells useful in regenerative medicine [7]. Among the possible sources, dental pulp 
is particularly interesting for ease retrieval, multipotency and bioethical considerations.  
Human dental pulp-derived stem cells (hDPSCs) show plastic adherence and are characterized by a 
typical fibroblast-like morphology. They express specific markers for mesenchymal stem cells (i.e. 
CD44, CD90, CD105, STRO-1) and are negative for hematopoietic markers (CD14, CD19), but capa-
ble of in vitro differentiation into odontoblasts, osteoblasts, chondrocytes, adipocytes and neurons [8-
10]. Several works have shown that hDPSCs represent a highly heterogeneous population with dis-
tinct clones and differences in proliferative and differentiating capacity [11, 12]. In particular, hDPSCs 
show the ability to differentiate into neuronal-like cells [13] or dopaminergic neuron-like cells [14]. It 
makes them as a cellular model candidate for the study and treatment of neurodegenerative diseases, 
such as Alzheimer, Parkinson and Huntington disease [15-17].  
Strong evidence shows relationship between cellular prion protein (PrPC) and stem cells. In fact, PrPC, 
a cell surface protein, is expressed in a wide variety of stem cells, including embryonic and hemato-
poietic stem cells and its function has been linked to stem cells biology modulating the proliferation 
and self-renewal of these cells [18-20]. 
PrPC is highly conserved in mammalian and is present on all nucleated cells, although it’s mainly ex-
pressed in the central and peripheral nervous system. PrPC is involved in many cellular processes, 
such as synaptic plasticity, calcium homeostasis, copper metabolism, apoptosis and cellular re-
sistance to oxidative stress [21-25]. A recent implication concerns the possible role of PrPC in neuronal 
differentiation processes of stem cells. In fact, during the neurogenic differentiation process, PrPC ex-
pression increases [26], since PrPC plays a role in neuritogenesis [20, 27]. Moreover, PrPC drives the 
differentiation of human embryonic stem cells into neurons, oligodendrocytes and astrocytes [28]. 
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The expression of PrPC makes mesenchymal stem cells good candidates to develop in vitro system 
for the study of prion infectivity and multiplication [15].  
Previous works suggest that lipid rafts and their components, as gangliosides, are essential for neu-
ronal differentiation of different types of stem cells [29-31].  
Since PrPC is a constitutively present in lipid rafts [32, 33] and in a wide variety of stem cells [18, 19], 
the purpose of this study was to investigate the possible role of PrPC during neuronal differentiation of 
human dental pulp-derived stem cells. 
  
2. RESULTS 
 
2.1. Characterization of hDPSCs and neuronal differentiation 
Stem cells were established from human dental pulp tissue isolated from third molars and cultivated 
as described above and in a precedent work [30]. In fact, the established cells expressed multipotent 
mesenchymal stromal specific surface antigens, such as CD44, CD90, CD105 and STRO1 [8, 30], but 
not the hematopoietic markers CD14 and CD19 [30]. Moreover, after stimulation with EGF/bFGF, 
hDPSCs slow their growth and after two weeks it was possible to observe neurites outgrowth (Fig. 1A) 
and the presence of specific neuronal markers, as 3-tubulin mAb (Fig. 1B). 
 
2.2. Presence of PrPC in established and neuronal differentiated hDPSCs by flow cytometry, 
western blot and immunofluorescence analysis 
In order to verify the presence of PrPC, we performed flow cytometry analysis of hDPSCs at 21 and 28 
days from dental pulp isolation and after neuronal differentiation with EGF/bFGF for additional 1 o 2 
weeks (7 and 14 days). As shown in figure 2A, flow cytometry analysis showed at 21 days a weakly 
positive staining for PrPC expression. This value increased at 28 days and after differentiation with 
EGF/bFGF a further increase in the expression (7 and 14 days) of the PrPC was observed. Moreover, 
to analyze simultaneous expression of antigens of staminality and PrPC in untreated hDPSCs or of 
neuronal marker and PrPC in EGF/bFGF stimulated cells, we developed double staining with anti-
CD44 or anti-3-tubulin and anti-PrP.  Flow cytometric analysis highlighted that in control hDPSCs 
more than 54% of cells were positive for CD44 and PrPC and, after neuronal differentiation, more than 
64% of the cells were positive for both antigens (PrPC and 3-tubulin) (Fig. 2B). The expression of 
PrPC in hDPSCs were confirmed by western blot (Fig. 2C) and fluorescence analysis (Fig. 2D). 
  
2.3. Association of PrPC with gangliosides and EGF-R in hDPSCs during neuronal differentia-
tion 
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Since several gangliosides [30, 31], as well as EGF receptor [34], have been shown to be components 
of the signaling complex within microdomains involved in neuronal differentiation of hDPSCs, we in-
vestigated the interaction of PrPC with gangliosides (GM2 and GD3) or EGF receptor. PrPC immuno-
precipitates from both hDPSCs, untreated or stimulated with EGF/bFGF for 2 weeks, were subjected 
to dot blot analysis. Immunolabeling with anti-GM2 showed that PrPC and GM2 were associated in 
control hDPSCs, but not in differentiated cells (Fig. 3A). On the contrary, labeling with anti-GD3 
showed association only in differentiated cells (Fig. 3B). Moreover, immunostaining with anti-EGF-R 
revealed that PrPC and EGF-R were weakly associated in control hDPSCs and this association was 
increased in differentiated cells for 2 weeks with EGF/bFGF (Fig. 3C). 
The immunoprecipitate was revealed as PrPC, as detected by dot blot, using the anti-PrP 6H4 mAb 
(Fig. 3D). In control samples the immunoprecipitation with IgG with irrelevant specificity, under the 
same condition, did not result in detectable levels of gangliosides or EGF-R (Fig. 3A-D). 
 
2.4. PrPC regulates signal pathways induced from EGF/EGF-R during neuronal differentiation of 
hDPSCs 
As reported from other authors [34], PrPC able to regulate the activation of MAP kinase and Protein 
Kinase B (Akt) by the modulation of EGF-R in N2a cells. In this context, we hypothesize that in hDP-
SCs PrPC may be able to regulate the activation of Akt and ERK1/2. hDPSCs, either untreated or 
treated with PrP siRNA for 72 h at 37°C, were stimulated with EGF for 5 min at 37°C. Western blot 
analysis showed the activation of Akt and ERK1/2 in the sample stimulated with EGF, while the activa-
tion was prevented in the sample pretreated with siRNA PrP plus EGF (Fig. 4).  
 
2.5. Plasma membrane PrPC is required for ERK and Akt activation 
PrPC is a GPI-anchored protein present in lipid rafts [35] and in intracellular compartment, such as en-
dosomes, rough endoplasmic reticulum and Golgi apparatus [36]. To understand which PrPC fraction 
is responsible for the activation of ERK1/2 and Akt, we used an anti-PrP SAF61, which is able to clus-
ter PrPC into cell membrane [37, 38]. hDPSCs, untreated or pre-treated with siRNA PrP for 72 h, were 
stimulated with SAF61 for 5 min at 37°C. Western blot analysis of p-ERK1/2 and p-Akt indicated that 
SAF61 induced their phosphorylation, which is significantly reduced after PrPC silencing (Fig. 5). The 
result show that PrPC plasma membrane is responsible for the activation of ERK and Akt signaling 
pathway in hDPSCs. 
 
2.6. Role of PrPC during neuronal differentiation of hDPSCs 
In order to evaluate the role of PrPC in the process of neuronal differentiation of hDPSCs, a small inter-
fering RNA (siRNA) was applied to ablate PrPC and its function. Flow cytometry analyses of siRNA-
treated cells revealed that PrPC expression appeared significantly reduced as compared to control 
cells (Fig. 6A); to verify the neuronal differentiation, hDPSCs were tested by western blot analysis with 
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3-tubulin (Fig. 6B) and NFH (Fig. 6C). The data show that silencing of PrPC by siRNA affected the 
neuronal differentiation process of hDPSCs, induced by EGF/bFGF after 2 weeks (Fig. 6B-C). 
 
 
3. DISCUSSION 
 
In this study we analyzed the role of cellular prion protein in hDPSCs isolated from third molars of 
healthy subjects and demonstrated a key role for PrPC during neural differentiation. hDPSCs were 
characterized in our previous work [30], revealing that these cells express well known multipotent 
mesenchymal stromal-specific surface antigens, such as CD44, CD90, CD105 and STRO-1 [9, 39, 
40]. The scientific literature has shown that these cells were able to differentiate to neurons after 
EGF/bFGF treatment [41, 42]. 
In a previous work [30] we reported that in hDPSCs lipid rafts were present and gangliosides repre-
sented major constituents [31]. GM2 was the most representative ganglioside in hDPSCs, while GD3 
was present exclusively during neuronal differentiation of human pulp-derived stem cells [30, 31]. In 
the present work we analyzed the presence of PrPC and its involvement in the neural differentiation 
process. First, we investigated the presence of PrPC in control and differentiated hDPSCs. Flow cy-
tometry analysis showed a weak staining at 21 days for PrPC expression and this value increased at 
28 days. After differentiation with EGF/bFGF, a further increase in the expression (7 and 14 days) of 
the PrPC was observed. 
These data are agreement with several authors who showed that PrPC is expressed in a wide variety 
of stem cells, including embryonic and hematopoietic stem cells [18, 19], where it is involved in the 
regulation of self-renewal, in their differentiation potential and in fate restriction of embryonic stem cell 
[43, 44]. 
Since it was already reported [45] that PrPC is associates with gangliosides within lipid rafts, we ana-
lyzed whether PrPC was associated with GM2 or GD3 in hDPSCs.  
Our results showed that PrPC is able to associate with GM2 specifically in control hDPSCs, whereas, 
after neuronal differentiation of hDPSCs, it associates preferentially with GD3. 
On the other hand, EGF receptor has been shown to be a component of the signaling complex within 
microdomains involved in several functions in N2a [34]. Thus, we investigated the interaction of PrPC 
with EGF receptor in hDPSCs. Dot blot analysis with anti-EGF-R of PrPC immunoprecipitates revealed 
that these two molecules are weakly associated within lipid rafts in control hDPSCs and the associa-
tion increases after neuronal differentiation of hDPSCs.  
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These data are supported by other authors, who highlighted the association of PrPC with two compo-
nents of the EGF-R macromolecular complex, such as Grb2 and p-Src. This indicates that PrPC may 
be part of the cell membrane complexes that regulate EGF/EGF-R signaling [34]. 
We hypothesized that, after neuronal induction, EGF-R is recruited within lipid rafts, where, interacting 
with PrPC , triggers the signal transduction.  
Indeed, lipid rafts are structures capable to concentrate specific receptors at cell plasma membrane, 
involved in signal transduction starter. On this basis, we evaluated whether PrPC might be able to reg-
ulates signal pathways induced from EGF/EGF-R during neuronal differentiation of hDPSCs. As re-
ported from other authors [34], PrPC is able to regulate the activation of MAP kinase and Protein Ki-
nase B (Akt) by the modulation of EGF-R in N2a cells and SK-N-SH. In this context, we hypothesized 
that in hDPSCs PrPC may be able to regulate the activation of ERK1/2 and Akt. In fact, siRNA PrP pre-
treatment for 72 h resulted in reduction of the activation of ERK1/2 and Akt induced by EGF. 
In our cellular model, we demonstrated that kinase activation (e.g., ERK1/2 and Akt) was mediated by 
the GPI-anchored plasma membrane PrPC and the association with EGF-R was increased after neu-
ronal induction. 
Since some authors had highlighted the role of PrPC during differentiation process and, in particular 
[27] PrPC contributes to the acquisition of neuronal polarization by modulating 1 integrin activity, we 
investigated the role of PrPC in the process of neuronal differentiation of hDPSCs. A small interfering 
RNA (siRNA PrP) was employed to ablate PrPC and its function. Silencing of PrPC by siRNA affected 
the neuronal differentiation process on hDPSCs, induced by EGF/bFGF for 2 weeks.  
These data pointed out the key role of PrPC in the process of neuronal differentiation in hDPSCs. Tak-
en together, our results suggest that PrPC interact with EGF-R within lipid rafts, playing a role in the 
multimolecular signaling complexes involved in hDPSCs neuronal differentiation.  
 
 
 
4. MATERIALS AND METHODS 
 
4.1. Isolation of stem cells derived from human dental pulp 
hDPSCs, isolated from third molar of healthy adult subjects (13 to 19 years old), were maintained in 
Dulbecco’s Modified Eagle’s Medium low glucose (DMEM-L), containing 100 units/ml penicillin, 10 
mg/ml streptomycin, plus 0,1% amphotericin (Sigma-Aldrich, Milan, Italy), plus 10% foetal bovin serum 
(FBS) (Life Technologies, Monza, Italy), at 37°C in humified CO2 atmosphere, as already described 
extensively in a previous work [30]. All samples were collected with informed consent of the patients 
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according to ethics considerations and after subscribed suitable set of forms and with the approval of 
the ethics committee.  
4.2. Treatments 
To induce neuronal differentiation, hDPSCs were cultured in appropriate induction media as previously 
described [41, 42]. Briefly, the cells were cultured up to 28 days from the pulp separation and subse-
quently stimulated with Neurobasal A medium containing L-Glutamine, supplemented with B27 (Life 
Technologies, Monza, Italy), basic Fibroblast Growth Factor 40 ng/ml (bFGF) and Epidermal Growth 
Factor 20 ng/ml (EGF) (PeproThec, DBA, Milan, Italy) for 7 and 14 days. For signaling experiments, 
undifferentiated hDPSCs were stimulated with EGF for 5 min at 37°C in 5% CO2; alternatively we used 
a mouse anti-PrP SAF61 mAb (Spi-Bio, Bertin Pharma, France), to cluster PrPC into the cell mem-
brane. 
 
4.3. Western blot analysis 
hDPSCs, untreated or treated with siRNA PrP for 72 h and stimulated with EGF alone (5 min) or in as-
sociation with bFGF (for 7 or 14 days) obtained as described below, were subjected to sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
Briefly, hDPSCs were lysed in lysis buffer containing 0,1% Triton X-100, 10mM Tris-HCl (pH 7.5), 
150mM NaCl, 5mM EDTA, 1mM Na3VO4 and 75 U of aprotinin and allowed to stand for 20 min at 
4°C. The cell suspension was mechanically disrupted by Dounce homogenization (10 strokes). The 
lysate was centrifuged for 5 min at 1300 x g to eliminate nuclei and large cellular debris and, after pro-
tein concentration analysis by Bradford Dye Reagent assay (Bio-Rad, Milano, Italia), the lysate was 
tested with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Subsequently, 
the proteins were electrophoretically transferred to PVDF membranes (Bio-Rad, Milan, Italia) that were 
blocked with 5% nonfat dried milk in TBS (Bio-Rad, Milan, Italia), containing 0.05% Tween 20 (Bio-
Rad, Milan, Italia), and probed with rabbit anti-p-ERK1/2 pAb, rabbit anti-total ERK1/2 pAb, rabbit anti-
p-Akt pAb, rabbit anti-total Akt pAb, mouse anti-β3-tubulin mAb, mouse anti-NFH mAb (Cell Signaling 
Technology Danvers, MA, USA), mouse anti-PrP SAF32 mAb (Spi-Bio, Bertin Pharma, France) and 
mouse anti-actin mAb (Sigma-Aldrich, Milan, Italy). Antibodies were visualized with horseradish perox-
idase (HRP)-conjugated anti-mouse IgG or anti-rabbit IgG (GE Healthcare Amersham Biosciences, 
Uppsala, Sweden) and immunoreactivity assessed by chemiluminescence reaction, using the ECL de-
tection system (Amersham, Buckingamshire, UK). Densitometric scanning analysis was accomplished 
with NIH Image 1.62 software by Mac OS X (Apple Computer International). 
 
4.4. Flow cytometry analysis 
Expression of PrPC on hDPSCs was quantified by flow cytometry after cell staining with rabbit anti-PrP 
mAb EP1802Y (Abcam, Cambridge, USA). As a negative control, we used rabbit IgG-CY5. hDPSCs at 
several times (21-28 day from dental pulp separation) or treated with EGF/bFGF (20 ng/ml and 40 
ng/ml respectively) for additional 7 and 14 day were fixed with 4% paraformaldehyde and permea-
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bilized by 0.1% (v/v) Triton X-100. After washing, cells were incubated with rabbit anti-PrP EP1802Y 
mAb for 1h at 4 °C, followed by CY5-conjugated anti-rabbit IgG H&L (Abcam, Cambridge, USA) for ad-
ditional 30 min. Alternatively we performed a double staining with rabbit anti-PrP EP1802Y mAb and 
mouse anti-CD44 mAb or mouse anti-3-tubulin mAb (Cell Signaling Technology, Danvers, MA, USA). 
All samples were analyzed with a FACScan cytometer (BD accuri C6 Flow cytometer) equipped with a 
blue laser (488 nm) and a red laser (640 nm). At least 20,000 events were acquired. 
 
4.5. Immunoprecipitation 
hDPSCs, untreated or treated with EGF/bFGF for 14 days were immunoprecipitated with mouse anti-
PrP SAF32 mAb (Spi-Bio, Bertin Pharma, France). Briefly, hDPSCs, stimulated as above, were lysed 
in lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 1 mM PMSF, 10 mg of 
leupeptin/ml). After preclearing, the supernatant was immunoprecipitated with mouse anti-PrP SAF32 
mAb (Spi-Bio, Bertin Pharma, France) plus protein A-acrylic beads. A mouse IgG isotypic control 
(Sigma-Aldrich, Milan, Italy) was used. The PrP
C
 immunoprecipitates were used for dot blot analysis.  
 
4.6. Dot blot analysis  
The PrPC immunoprecipitates, obtained as reported above, were transferred onto nitrocellulose mem-
branes (Bio-Rad, Milan, Italia). Dot blot analysis was performed as described by Garofalo et al 2016 
(46). Briefly nitrocellulose strips were probed with: rabbit anti-EGF-R pAb (Santa Cruz, CA, USA), 
mouse anti-GM2 IgM mAb (NANA) and mouse anti-GD3 IgM mAb (Seikagaku Corp., Chou-ku, Tokyo, 
Japan). They were then incubated with the corresponding species-specific secondary antibodies and 
immunoreactivity was visualized using the ECL Western detection system. The immunoprecipitates 
were checked by anti-PrP 6H4 mAb (Prionics, Milan, Italy).  
 
4.7. Knockdown PrPC by siRNA 
hDPSCs were seeded (8×104 cells/ml) 6-well plates, in DMEM-L containing serum and antibiotics. 
Twenty-four hours after seeding, cells were transfected with 5 nM siRNA PrP (Flexitube GeneSolution 
GS5621 for PRNP), using HiPerFect Transfection Reagent (Qiagen, Valencia, CA), according to the 
manufacturer’s instructions. As experimental control, cells were also transfected with 5 nM scrambled 
siRNA (AllStars Negative Control - Qiagen). After 72 h, cells were incubated with EGF (PeproThec, 
DBA, Milan, Italy) for 5 min at 37°C or, alternatively, with EGF/bFGF for 7 and 14 days. PrPC expres-
sion was verified by flow cytometry analysis by using rabbit anti-PrP EP1802Y mAb (Abcam, Cam-
bridge, USA). 
 
4.8. Immunofluorescence analysis 
hDPSCs were seeded (2×104 cells/ml) 6-well plates, in DMEM-L containing serum and antibiotics. 
Twenty-four after seeding, cells were stimulated with EGF/bFGF (20 ng/ml and 40 ng/ml respectively) 
for 14 days and used for immunofluorescence analysis. Briefly, hDPSCs treated as above were fixed 
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with 4% paraformaldehyde and permeabilized by 0.1% (v/v) Triton X-100. After washing, cells were in-
cubated with mouse anti-3-tubulin mAb (Cell Signaling Technology, Danvers, MA, USA) or alternative-
ly, with mouse anti-PrP SAF32 mAb (Spi-Bio, Bertin Pharma, France) for 1h at 4°C, followed by anti-
mouse Alexa fluor 488 (ThermoFisher Scientific, Rockford, USA) for additional 30 min. Finally, cells 
were observed with a Zeiss Axio Vert. A1 fluorescence microscope (Zeiss, Milan, Italy). 
 
4.9. Statistical analysis  
Western blot images were subjected to densitometric scanning analysis, performed by Mac OS X (Ap-
ple Computer International), using NIH Image 1.62 software All data reported in this paper were veri-
fied in at least 3 different experiments and reported as mean ± standard deviation (SD). Only p values 
of <0.01 were considered as statistically significant.  
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FIGURE LEGENDS 
 
Fig. 1. Differentiation of hDPSCs. (A) Morphology of hDPSCs from dental pulp untreated and treated 
with EGF/bFGF for 14 days. Scale bars, 50 m. (B) Immunofluorescence analysis of neuronal marker 
3-tubulin mAb expression. Scale bars, 50 m.  
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Fig. 2. PrPC expression in hDSPCs. (A) Flow cytometry analysis of PrPC expression at 21 and 28 
days from dental pulp separation and after additional 7 and 14 days with EGF/bFGF. Histograms rep-
resent log fluorescence vs cell number, gated on cell population of a side scatter/forward scatter 
(SS/FS) histogram. Cell number is indicated on the y-axis and fluorescence intensity is represented on 
the x-axis. Each panel was compared with the corresponding IgG negative isotype control. A repre-
sentative experiment among 3 is shown. (B) Double staining flow cytometry analysis of PrP/CD44 in 
control hDPSCs (28 days from pulp separation) and PrP/3-tubulin after stimulation with EGF/bFGF 
for additional 14 days. Histograms represent log fluorescence PE vs log fluorescence CY5, gated on 
cell population of a side scatter/forward scatter (SS/FS) histogram. CD44-PE fluorescence is indicated 
on the y-axis and PrP-CY5 fluorescence intensity is represented on the x-axis. Each panel was com-
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pared with the corresponding IgG negative isotype control. A representative experiment among 3 is 
shown. (C) Western blot analysis of PrPC expression at 21 and 28 days from dental pulp separation 
and after additional 7 and 14 days with EGF/bFGF, using anti-PrP SAF32. Loading control was evalu-
ated using anti--actin. Densitometric analysis of bands from the representative western blot is report-
ed in panel on the right as Mean ± SD. 
 
 
 
 
Fig. 3. Analysis of PrPC association with gangliosides and EGF-R by coimmunoprecipitation. 
hDPSCs, untreated or treated with EGF/bFGF for 14 days, were lysed in lysis buffer, followed by im-
munoprecipitation with anti-PrP SAF32. A mouse IgG isotypic control was employed. The immunopre-
cipitates were spotted onto nitrocellulose, and incubated with anti-GM2 (A), anti-GD3 (B) and anti-
EGF-R (C), as described in Materials and methods. A representative experiment among 3 is shown. 
Bar graph in the right panel shows densitometric analysis. Results represent the Mean + SD from 3 
independent experiments, *p<0.01. The immunoprecipitates were checked using the anti-PrP 6H4 (D). 
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Fig. 4. Effects of PrPC silencing on ERK and Akt phosphorylation induced by EGF. hDPSCs, un-
treated or treated with 20 ng/ml EGF, in the presence or in the absence of pre-treatment with siRNA 
PrP or scrambled siRNA, were analyzed by Western blot, using anti-pERK1/2, anti-total ERK1/2 (A), 
anti-pAkt and anti-total Akt (B), Densitometric analysis is shown in the right. Results represent the 
Mean+SD from 3 independent experiments, *p <0.01 siRNA PrP treated cells vs EGF treated cells. As 
control, scrambled siRNA was employed in each experiment. 
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Fig. 5. Plasma membrane PrPC is required for signal transduction. hDPSCs cells, treated with 
siRNA PrP or scrambled for 72 hours, were stimulated with anti PrP SAF61 mAb for 10 min and ana-
lyzed by Western blot, using anti-pERK1/2, anti-total ERK1/2 (A), anti-pAkt, and anti-total Akt (B). 
Densitometric analysis is shown in the right panel. Results represent the Mean+SD from 3 independ-
ent experiments, *p<0.01 siRNA PrP treated cells vs SAF61 treated cells. 
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Fig. 6. Role of PrPC during neuronal differentiation of hDPSCs induced by EGF/bFGF. 
(A) Flow cytometry analysis of PrPC expression in hDPSCs, untreated or treated with siRNA PrP for 72 
hours. Histograms represent log fluorescence vs cell number, gated on cell population of a side scat-
ter/forward scatter (SS/FS) histogram. Cell number is indicated on the y-axis and fluorescence intensi-
ty is represented on the x-axis. Each panel was compared with the corresponding IgG negative iso-
type control. A representative experiment among 3 is shown. (B-C) Western blot analysis of 3-
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tubulin, and NFH expression in hDPSCs, untreated or treated with 20 ng/ml EGF and 40 ng/ml bFGF 
for 14 days, in the presence or in the absence of pre-treatment with siRNA PrP or scrambled siRNA 
for 72 hours. Densitometric analysis is shown in the right panel. Results represent the Mean+SD from 
3 independent experiments. *p<0.01 siRNAPrP treated cells vs EGF/bFGF treated cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
